Latest Breaking News On - Julie rathbun - Page 8 : vimarsana.com

Athira Pharma Presents Preclinical Data at the Alzheimer s Association International Conference 2022

Athira Pharma Presents Preclinical Data at the Alzheimer s Association International Conference 2022
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesAthira pharmaJulie rathbunAlzheimer association international conferenceResearch at athiraAthira pharma incExchange commissionKevin churchSecurities exchangeAssociation international conferenceExecutive vice presidentScientific publicationsPharma incSecurities actSecurities exchange actPrivate securities litigation reform act

Athira Pharma Presents Preclinical Data at the Alzheimer s

Fosgo-AM, the active metabolite of Fosgonimeton (ATH-1017), demonstrates neuroprotective effects in primary neuron culturesNew orally available small.

United statesAthira pharmaJulie rathbunAlzheimer association international conferenceResearch at athiraAthira pharma incExchange commissionKevin churchSecurities exchangeAssociation international conferenceExecutive vice presidentScientific publicationsPharma incSecurities actSecurities exchange actPrivate securities litigation reform act

Shareholders Approve the Election of All Three Athira

BOTHELL, Wash., May 19, 2022 (GLOBE NEWSWIRE) Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on.

Mark littonJoseph edelmanAthira pharmaWilson sonsini goodrich rosatiWilkinson brimmer katcherJulie rathbunJoele frankExchange commissionAthira pharma incGoldman sachs coSecurities exchangeGrant pickeringChief executive officer markAnnual meetingWilson sonsini goodrichPharma inc

Athira Pharma Reports First Quarter 2022 Financial Results and Provides Pipeline and Business Updates

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesAthira pharmaSimon daggettArthur rosenthalJulie rathbunMichael panzaraLana gloukhovaMark littonDonald mackenziePeripheral nerve societyAthira pharma incAvanir pharmaceuticalsNational institutes of healthWorld health organizationDrug regulatory affairsAmerican society for experimental neurotherapeutics

Mozart Therapeutics Presents Data at IMMUNOLOGYTM 2022 Highlighting Novel CD8 Treg Network in Celiac Disease and Other Autoimmune Diseases

/PRNewswire/ Mozart Therapeutics, a leading developer of CD8 Treg modulators in autoimmune and inflammatory disease, today announced the presentation of.

United statesKristine swiderekJulie rathbunAmerican association of immunologistsRathbun communicationsMozart therapeuticsAmerican associationAnnual meetingChief scientific officer